edgepedia

Hypertrophic cardiomyopathy

9 articles

Athlete's heart

Athlete's heart is the benign set of changes, including chamber enlargement and a slow resting heart rate, that regular athletic training produces; it can mimic hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy screening

Hypertrophic cardiomyopathy screening detects the genetic thickened-heart disease (HCM, about 1 in 500 people) in athletes and relatives using history, physical, ECG, echo, MRI, and genetic testing; ECG raises sensitivity from 15-40% to 87-100%.

MYH7

MYH7 (myosin heavy chain 7) is a chromosome 14 gene encoding beta-myosin heavy chain of the cardiac sarcomere; variants cause hypertrophic and dilated cardiomyopathy, Laing distal myopathy, and myosin storage myopathy.

Non-obstructive hypertrophic cardiomyopathy

Non-obstructive hypertrophic cardiomyopathy (nHCM, ICD-11 BC43.11) is HCM without a significant LVOT pressure gradient (LVOT <30 mmHg at rest and provoked), treated with beta blockers or verapamil/diltiazem, with no approved targeted therapy.

Obstructive hypertrophic cardiomyopathy

Obstructive hypertrophic cardiomyopathy (HOCM) is the form of hypertrophic cardiomyopathy in which thickened heart muscle and mitral valve motion block blood leaving the left ventricle, affecting about 70% of patients.

Septal myectomy

Septal myectomy is an open-heart operation removing part of the thickened septum to relieve left ventricular outflow obstruction in hypertrophic cardiomyopathy, with mortality below 1% at experienced centers.

Srihari S. Naidu

Srihari S. Naidu is an American interventional cardiologist known for hypertrophic cardiomyopathy and alcohol septal ablation, directing the HCM Program at Westchester Medical Center in Valhalla, New York.

Sudden cardiac death in hypertrophic cardiomyopathy

Sudden cardiac death in hypertrophic cardiomyopathy is the leading cause of death in HCM; risk scores such as HCM Risk-SCD estimate five-year risk to guide implantable cardioverter-defibrillator decisions.

Ulrich Sigwart

Ulrich Sigwart (born 1941, Wuppertal) is a cardiologist who pioneered coronary stenting (Wallstent, first bailout implantation 1986) and invented alcohol septal ablation for hypertrophic obstructive cardiomyopathy; ESC Gold Medal 2025.